Company intelligence / Profile preview

BIRMEX

Mexico City, Ciudad de México, Mexicogob.mx ↗
Ownership
Private
Employees
~1500
Development stage
Other
01

Overview

BIRMEX is a Mexican state-owned pharmaceutical enterprise dedicated to the research, development, production, and distribution of biological products and reagents. The company is globally recognized for its expertise in producing hyperimmune sera, particularly antivenoms for snake, scorpion, and spider bites. In addition to its manufacturing role, BIRMEX serves as a strategic pillar for the Mexican healthcare system by managing national vaccine supplies and operating large-scale logistics hubs. Recently, its mandate has expanded to include the centralized distribution of medications through the 'Megafarmacia del Bienestar' to ensure drug availability across Mexico's public health institutions. The company also engages in international technology transfers and fill-finish operations for various essential vaccines.

Therapeutic areas
OtherInfectious Diseases
Modalities
VaccineBiologicSmall molecule
Industry
Biotech
02

Drug pipeline

4 assets

scorpion antivenom (equine)

4

3 more assets in the full pipeline.

Request access →
03

Partnerships

SanofiGamaleya Research Institute of Epidemiology and MicrobiologySerum Institute of India

Beyond the preview

Go deeper on BIRMEX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BIRMEX.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call